Colostrum-based nutrition and biotechnology company PanTheryx announced today that it acquired TruBiotics, a daily probiotic supplement brand, and its trademarks from Bayer HealthCare LLC. TruBiotics, a well-recognized probiotic brand in the U.S. with products available at food, drug, and mass channel retailers and on e-commerce outlets, will join PanTheryx’s current brands and ingredient offerings, including Life’s First Naturals, dairy colostrum, and prebiotics, to create a full spectrum of nutritional supplements that support digestive and immune health at all stages of life.
 
“The acquisition of TruBiotics is consistent with our strategy to accelerate growth through acquisitions of synergistic brands in fast-growing strategic categories,” Wes Parris, president and CEO of PanTheryx, said. “We are looking forward to accelerating growth in the probiotics and microbiome category through innovation and investment behind this well-established and high-quality brand.”
 
TruBiotics contains a proprietary blend of two probiotic strains – Bifidobacterium animalis BB-12 and Lactobacillus acidophilus LA-5, which is one of the most researched combinations of probiotic strains, PanTheryx said, with evidence that both are supportive of immune and digestive health.
 
“Delivering strong TruBiotics Growth is a strategic priority and we are pleased that Bayer is entrusting PanTheryx with the future of this highly respected probiotic brand,” David Abramson, executive chairman of the board of PanTheryx, said. “We could not be more energized by this naturally synergistic acquisition. With the leader of our management team having previously led the building of the number one probiotic brand in the world, we look forward to rapidly accelerating market penetration of TruBiotics. We anticipate strong growth in the U.S., and additionally in other major international markets and new distribution channels globally. With many years of experience in the immune health, digestive health, and microbiome category, PanTheryx is ideally positioned to ensure TruBiotics reaches its full potential within the health and wellness sector.”
 
According to Grandview Research, the global probiotics market is poised to reach $77 billion by 2025. The growth of this market is driven by heightened awareness of preventive healthcare among consumers, research focused on the multiple health benefits of probiotics, and increased usage of probiotics as alternatives to antibiotics.
 
“An extensive body of research demonstrates the benefits of probiotics in supporting a healthy digestive and immune system,” said Mehmet Oz, M.D., attending physician at New York Presbyterian – Columbia Medical Center, host of The Dr. Oz Show, and PanTheryx board member. “Probiotics are live microorganisms that have been shown to have health benefits when consumed or applied to the body. They can be found naturally in yogurt, fermented foods and in beauty products, and for people who do not eat these foods or use topicals regularly, there are high-quality probiotic supplements that can help them achieve their digestive health and immune health goals. I’m excited to see PanTheryx commit to the rapidly growing category of probiotics and I look forward to helping consumers better understand the wonderful health benefits in this area.”
 
TruBiotics will continue to be available through existing retail and e-commerce channels, and will be marketed under the PanTheryx portfolio of products.